Herold Advisors, Inc. Cara Therapeutics, Inc. Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$7.45 - $13.84 $5,960 - $11,072	-800 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$9.94 - $12.65 $7,952 - $10,120	800 New	800 $9,000
Q4 2021 Jan 20, 2022	SELL	$11.99 - $18.14 $22,781 - $34,466	-1,900 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$11.55 - $16.06 $21,945 - $30,513	1,900 New	1,900 $29,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.